nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—VEGFA—brain cancer	0.458	0.565	CbGaD
Gliclazide—CYP2C9—brain cancer	0.352	0.435	CbGaD
Gliclazide—VEGFA—miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma —HEY1—brain cancer	0.00445	0.0788	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—RASSF1—brain cancer	0.00235	0.0417	CbGpPWpGaD
Gliclazide—VEGFA—miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma —HES1—brain cancer	0.0023	0.0408	CbGpPWpGaD
Gliclazide—VEGFA—NOTCH1 regulation of human endothelial cell calcification—DLL1—brain cancer	0.00214	0.038	CbGpPWpGaD
Gliclazide—VEGFA—Alpha9 beta1 integrin signaling events—TGM2—brain cancer	0.00208	0.0368	CbGpPWpGaD
Gliclazide—VEGFA—Differentiation Pathway—ALK—brain cancer	0.00191	0.0339	CbGpPWpGaD
Gliclazide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00183	0.0324	CbGpPWpGaD
Gliclazide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00166	0.0295	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—DAPK1—brain cancer	0.00152	0.0269	CbGpPWpGaD
Gliclazide—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00142	0.0251	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—NTRK3—brain cancer	0.00133	0.0235	CbGpPWpGaD
Gliclazide—Glimepiride—CYP2C9—brain cancer	0.0013	0.283	CrCbGaD
Gliclazide—Glipizide—CYP2C9—brain cancer	0.00112	0.246	CrCbGaD
Gliclazide—VEGFA—Heart Development—HEY1—brain cancer	0.00102	0.0181	CbGpPWpGaD
Gliclazide—VEGFA—Beta1 integrin cell surface interactions—TGM2—brain cancer	0.000956	0.0169	CbGpPWpGaD
Gliclazide—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000877	0.0156	CbGpPWpGaD
Gliclazide—VEGFA—Heart Development—SHH—brain cancer	0.000852	0.0151	CbGpPWpGaD
Gliclazide—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000844	0.015	CbGpPWpGaD
Gliclazide—VEGFA—Angiogenesis—PDGFRA—brain cancer	0.000818	0.0145	CbGpPWpGaD
Gliclazide—Chlorpropamide—CYP2C9—brain cancer	0.000813	0.178	CrCbGaD
Gliclazide—VEGFA—Differentiation Pathway—SHH—brain cancer	0.000794	0.0141	CbGpPWpGaD
Gliclazide—Tolbutamide—CYP2C9—brain cancer	0.000792	0.173	CrCbGaD
Gliclazide—VEGFA—Alpha9 beta1 integrin signaling events—SPP1—brain cancer	0.000769	0.0136	CbGpPWpGaD
Gliclazide—VEGFA—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000675	0.012	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—EHMT1—brain cancer	0.000612	0.0108	CbGpPWpGaD
Gliclazide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000602	0.0107	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—PTCH1—brain cancer	0.000598	0.0106	CbGpPWpGaD
Gliclazide—VEGFA—telencephalon—brain cancer	0.000594	0.0874	CbGeAlD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—HES5—brain cancer	0.000582	0.0103	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—PPP1R12A—brain cancer	0.000552	0.00978	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—CDK4—brain cancer	0.000549	0.00974	CbGpPWpGaD
Gliclazide—Glyburide—CYP2C9—brain cancer	0.000549	0.12	CrCbGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—MPL—brain cancer	0.00051	0.00904	CbGpPWpGaD
Gliclazide—VEGFA—Beta3 integrin cell surface interactions—SPP1—brain cancer	0.000498	0.00883	CbGpPWpGaD
Gliclazide—VEGFA—pituitary gland—brain cancer	0.000483	0.0712	CbGeAlD
Gliclazide—ABCC8—brainstem—brain cancer	0.000441	0.0649	CbGeAlD
Gliclazide—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000421	0.00747	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—CDKN2A—brain cancer	0.00042	0.00744	CbGpPWpGaD
Gliclazide—VEGFA—spinal cord—brain cancer	0.000416	0.0613	CbGeAlD
Gliclazide—VEGFA—Bladder Cancer—ERBB2—brain cancer	0.000401	0.00712	CbGpPWpGaD
Gliclazide—ABCC8—telencephalon—brain cancer	0.000391	0.0576	CbGeAlD
Gliclazide—VEGFA—Integrins in angiogenesis—SPP1—brain cancer	0.000367	0.00651	CbGpPWpGaD
Gliclazide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000364	0.00646	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—SPP1—brain cancer	0.000362	0.00643	CbGpPWpGaD
Gliclazide—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000359	0.00637	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—CCND1—brain cancer	0.000355	0.00629	CbGpPWpGaD
Gliclazide—VEGFA—Beta1 integrin cell surface interactions—SPP1—brain cancer	0.000354	0.00627	CbGpPWpGaD
Gliclazide—VEGFA—cerebellum—brain cancer	0.00033	0.0486	CbGeAlD
Gliclazide—Myalgia—Procarbazine—brain cancer	0.000323	0.00264	CcSEcCtD
Gliclazide—Arthralgia—Procarbazine—brain cancer	0.000323	0.00264	CcSEcCtD
Gliclazide—Anxiety—Procarbazine—brain cancer	0.000322	0.00263	CcSEcCtD
Gliclazide—ABCC8—pituitary gland—brain cancer	0.000318	0.0469	CbGeAlD
Gliclazide—Bronchitis—Temozolomide—brain cancer	0.000317	0.00259	CcSEcCtD
Gliclazide—Dry mouth—Procarbazine—brain cancer	0.000316	0.00259	CcSEcCtD
Gliclazide—VEGFA—Allograft Rejection—PDGFRA—brain cancer	0.000316	0.00559	CbGpPWpGaD
Gliclazide—Pancytopenia—Temozolomide—brain cancer	0.000313	0.00256	CcSEcCtD
Gliclazide—Cardiac failure—Etoposide—brain cancer	0.000312	0.00256	CcSEcCtD
Gliclazide—Confusional state—Procarbazine—brain cancer	0.000312	0.00255	CcSEcCtD
Gliclazide—Vomiting—Lomustine—brain cancer	0.00031	0.00254	CcSEcCtD
Gliclazide—Infection—Procarbazine—brain cancer	0.000308	0.00252	CcSEcCtD
Gliclazide—Hyperglycaemia—Carmustine—brain cancer	0.000307	0.00251	CcSEcCtD
Gliclazide—ABCC8—medulla oblongata—brain cancer	0.000307	0.0453	CbGeAlD
Gliclazide—Upper respiratory tract infection—Temozolomide—brain cancer	0.000306	0.0025	CcSEcCtD
Gliclazide—Pneumonia—Carmustine—brain cancer	0.000306	0.0025	CcSEcCtD
Gliclazide—Erectile dysfunction—Temozolomide—brain cancer	0.000303	0.00248	CcSEcCtD
Gliclazide—Thrombocytopenia—Procarbazine—brain cancer	0.000303	0.00248	CcSEcCtD
Gliclazide—Depression—Carmustine—brain cancer	0.000303	0.00248	CcSEcCtD
Gliclazide—Chills—Hydroxyurea—brain cancer	0.000303	0.00248	CcSEcCtD
Gliclazide—Tachycardia—Procarbazine—brain cancer	0.000302	0.00247	CcSEcCtD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—VAV1—brain cancer	0.000302	0.00536	CbGpPWpGaD
Gliclazide—Photosensitivity reaction—Temozolomide—brain cancer	0.000301	0.00246	CcSEcCtD
Gliclazide—Weight increased—Temozolomide—brain cancer	0.0003	0.00245	CcSEcCtD
Gliclazide—Hyperhidrosis—Procarbazine—brain cancer	0.000299	0.00245	CcSEcCtD
Gliclazide—Renal failure—Carmustine—brain cancer	0.000299	0.00244	CcSEcCtD
Gliclazide—Neuropathy peripheral—Carmustine—brain cancer	0.000298	0.00244	CcSEcCtD
Gliclazide—Hyperglycaemia—Temozolomide—brain cancer	0.000297	0.00243	CcSEcCtD
Gliclazide—Urinary tract infection—Carmustine—brain cancer	0.000295	0.00242	CcSEcCtD
Gliclazide—Pneumonia—Temozolomide—brain cancer	0.000295	0.00242	CcSEcCtD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000295	0.00524	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000295	0.00522	CbGpPWpGaD
Gliclazide—Erythema—Hydroxyurea—brain cancer	0.000294	0.0024	CcSEcCtD
Gliclazide—Depression—Temozolomide—brain cancer	0.000293	0.0024	CcSEcCtD
Gliclazide—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000291	0.00238	CcSEcCtD
Gliclazide—Nausea—Lomustine—brain cancer	0.00029	0.00237	CcSEcCtD
Gliclazide—Hypotension—Procarbazine—brain cancer	0.000289	0.00237	CcSEcCtD
Gliclazide—Neuropathy peripheral—Temozolomide—brain cancer	0.000288	0.00235	CcSEcCtD
Gliclazide—Urinary tract infection—Temozolomide—brain cancer	0.000285	0.00233	CcSEcCtD
Gliclazide—VEGFA—Signaling by VEGF—VAV1—brain cancer	0.000285	0.00506	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—MYC—brain cancer	0.000285	0.00504	CbGpPWpGaD
Gliclazide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000282	0.00231	CcSEcCtD
Gliclazide—ABCC8—midbrain—brain cancer	0.000281	0.0414	CbGeAlD
Gliclazide—Insomnia—Procarbazine—brain cancer	0.00028	0.00229	CcSEcCtD
Gliclazide—VEGFA—Bladder Cancer—EGFR—brain cancer	0.000278	0.00493	CbGpPWpGaD
Gliclazide—Paraesthesia—Procarbazine—brain cancer	0.000278	0.00228	CcSEcCtD
Gliclazide—Hepatobiliary disease—Temozolomide—brain cancer	0.000278	0.00227	CcSEcCtD
Gliclazide—Sinusitis—Temozolomide—brain cancer	0.000276	0.00225	CcSEcCtD
Gliclazide—Somnolence—Procarbazine—brain cancer	0.000275	0.00225	CcSEcCtD
Gliclazide—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000275	0.00225	CcSEcCtD
Gliclazide—ABCC8—spinal cord—brain cancer	0.000274	0.0404	CbGeAlD
Gliclazide—Ill-defined disorder—Hydroxyurea—brain cancer	0.000273	0.00223	CcSEcCtD
Gliclazide—Anaemia—Hydroxyurea—brain cancer	0.000272	0.00222	CcSEcCtD
Gliclazide—Hypoaesthesia—Carmustine—brain cancer	0.000271	0.00222	CcSEcCtD
Gliclazide—Oedema peripheral—Carmustine—brain cancer	0.000269	0.0022	CcSEcCtD
Gliclazide—VEGFA—brain—brain cancer	0.000268	0.0394	CbGeAlD
Gliclazide—KCNJ11—endocrine gland—brain cancer	0.000268	0.0394	CbGeAlD
Gliclazide—Fatigue—Procarbazine—brain cancer	0.000267	0.00218	CcSEcCtD
Gliclazide—VEGFA—Heart Development—CTNNB1—brain cancer	0.000265	0.00471	CbGpPWpGaD
Gliclazide—Malaise—Hydroxyurea—brain cancer	0.000265	0.00217	CcSEcCtD
Gliclazide—Constipation—Procarbazine—brain cancer	0.000265	0.00217	CcSEcCtD
Gliclazide—Pain—Procarbazine—brain cancer	0.000265	0.00217	CcSEcCtD
Gliclazide—KCNJ11—head—brain cancer	0.000264	0.0389	CbGeAlD
Gliclazide—Hepatitis—Temozolomide—brain cancer	0.000264	0.00216	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000263	0.00467	CbGpPWpGaD
Gliclazide—Leukopenia—Hydroxyurea—brain cancer	0.000263	0.00215	CcSEcCtD
Gliclazide—Visual impairment—Carmustine—brain cancer	0.000263	0.00215	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—MPL—brain cancer	0.000263	0.00466	CbGpPWpGaD
Gliclazide—Hypoaesthesia—Temozolomide—brain cancer	0.000262	0.00215	CcSEcCtD
Gliclazide—Pharyngitis—Temozolomide—brain cancer	0.000262	0.00214	CcSEcCtD
Gliclazide—Oedema peripheral—Temozolomide—brain cancer	0.00026	0.00212	CcSEcCtD
Gliclazide—Feeling abnormal—Procarbazine—brain cancer	0.000255	0.00209	CcSEcCtD
Gliclazide—Eye disorder—Carmustine—brain cancer	0.000255	0.00209	CcSEcCtD
Gliclazide—Convulsion—Hydroxyurea—brain cancer	0.000255	0.00208	CcSEcCtD
Gliclazide—Visual impairment—Temozolomide—brain cancer	0.000254	0.00208	CcSEcCtD
Gliclazide—Gastrointestinal pain—Procarbazine—brain cancer	0.000253	0.00207	CcSEcCtD
Gliclazide—Flushing—Carmustine—brain cancer	0.000253	0.00207	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—S100A10—brain cancer	0.000252	0.00447	CbGpPWpGaD
Gliclazide—Pancytopenia—Etoposide—brain cancer	0.00025	0.00205	CcSEcCtD
Gliclazide—VEGFA—Signaling events mediated by TCPTP—STAT3—brain cancer	0.00025	0.00443	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000249	0.00442	CbGpPWpGaD
Gliclazide—Erythema multiforme—Temozolomide—brain cancer	0.000249	0.00204	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000248	0.00203	CcSEcCtD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000248	0.00439	CbGpPWpGaD
Gliclazide—Discomfort—Hydroxyurea—brain cancer	0.000247	0.00202	CcSEcCtD
Gliclazide—ABCC8—endocrine gland—brain cancer	0.000247	0.0363	CbGeAlD
Gliclazide—Eye disorder—Temozolomide—brain cancer	0.000246	0.00202	CcSEcCtD
Gliclazide—Urticaria—Procarbazine—brain cancer	0.000246	0.00201	CcSEcCtD
Gliclazide—Tinnitus—Temozolomide—brain cancer	0.000246	0.00201	CcSEcCtD
Gliclazide—Abdominal pain—Procarbazine—brain cancer	0.000245	0.002	CcSEcCtD
Gliclazide—Body temperature increased—Procarbazine—brain cancer	0.000245	0.002	CcSEcCtD
Gliclazide—Flushing—Temozolomide—brain cancer	0.000245	0.002	CcSEcCtD
Gliclazide—Arrhythmia—Carmustine—brain cancer	0.000244	0.00199	CcSEcCtD
Gliclazide—ABCC8—head—brain cancer	0.000244	0.0359	CbGeAlD
Gliclazide—KCNJ11—central nervous system—brain cancer	0.000241	0.0355	CbGeAlD
Gliclazide—Mental disorder—Carmustine—brain cancer	0.000239	0.00195	CcSEcCtD
Gliclazide—ABCC8—Transmembrane transport of small molecules—S100A10—brain cancer	0.000239	0.00423	CbGpPWpGaD
Gliclazide—Infection—Hydroxyurea—brain cancer	0.000238	0.00195	CcSEcCtD
Gliclazide—Erythema—Carmustine—brain cancer	0.000237	0.00194	CcSEcCtD
Gliclazide—Malnutrition—Carmustine—brain cancer	0.000237	0.00194	CcSEcCtD
Gliclazide—Chills—Temozolomide—brain cancer	0.000237	0.00193	CcSEcCtD
Gliclazide—Pneumonia—Etoposide—brain cancer	0.000236	0.00193	CcSEcCtD
Gliclazide—KCNJ11—cerebellum—brain cancer	0.000236	0.0347	CbGeAlD
Gliclazide—Nervous system disorder—Hydroxyurea—brain cancer	0.000235	0.00192	CcSEcCtD
Gliclazide—Thrombocytopenia—Hydroxyurea—brain cancer	0.000235	0.00192	CcSEcCtD
Gliclazide—VEGFA—Bladder Cancer—TP53—brain cancer	0.000234	0.00414	CbGpPWpGaD
Gliclazide—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000233	0.00191	CcSEcCtD
Gliclazide—Skin disorder—Hydroxyurea—brain cancer	0.000233	0.0019	CcSEcCtD
Gliclazide—Acute coronary syndrome—Etoposide—brain cancer	0.000232	0.00189	CcSEcCtD
Gliclazide—Renal failure—Etoposide—brain cancer	0.000231	0.00189	CcSEcCtD
Gliclazide—Mental disorder—Temozolomide—brain cancer	0.000231	0.00189	CcSEcCtD
Gliclazide—Myocardial infarction—Etoposide—brain cancer	0.00023	0.00188	CcSEcCtD
Gliclazide—Neuropathy peripheral—Etoposide—brain cancer	0.00023	0.00188	CcSEcCtD
Gliclazide—Back pain—Carmustine—brain cancer	0.00023	0.00188	CcSEcCtD
Gliclazide—Erythema—Temozolomide—brain cancer	0.000229	0.00188	CcSEcCtD
Gliclazide—Malnutrition—Temozolomide—brain cancer	0.000229	0.00188	CcSEcCtD
Gliclazide—Jaundice—Etoposide—brain cancer	0.000229	0.00187	CcSEcCtD
Gliclazide—Hypersensitivity—Procarbazine—brain cancer	0.000228	0.00187	CcSEcCtD
Gliclazide—VEGFA—Signaling events mediated by TCPTP—EGFR—brain cancer	0.000227	0.00402	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000226	0.004	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—RELA—brain cancer	0.000223	0.00396	CbGpPWpGaD
Gliclazide—Tremor—Carmustine—brain cancer	0.000222	0.00182	CcSEcCtD
Gliclazide—ABCC8—central nervous system—brain cancer	0.000222	0.0327	CbGeAlD
Gliclazide—Asthenia—Procarbazine—brain cancer	0.000222	0.00182	CcSEcCtD
Gliclazide—Hepatobiliary disease—Etoposide—brain cancer	0.000222	0.00182	CcSEcCtD
Gliclazide—Back pain—Temozolomide—brain cancer	0.000222	0.00182	CcSEcCtD
Gliclazide—VEGFA—SHP2 signaling—IL2—brain cancer	0.00022	0.00391	CbGpPWpGaD
Gliclazide—Anaemia—Carmustine—brain cancer	0.000219	0.0018	CcSEcCtD
Gliclazide—Agranulocytosis—Etoposide—brain cancer	0.000219	0.00179	CcSEcCtD
Gliclazide—Pruritus—Procarbazine—brain cancer	0.000219	0.00179	CcSEcCtD
Gliclazide—Agitation—Carmustine—brain cancer	0.000218	0.00179	CcSEcCtD
Gliclazide—ABCC8—cerebellum—brain cancer	0.000217	0.032	CbGeAlD
Gliclazide—Tremor—Temozolomide—brain cancer	0.000215	0.00176	CcSEcCtD
Gliclazide—Dyspnoea—Hydroxyurea—brain cancer	0.000214	0.00175	CcSEcCtD
Gliclazide—Somnolence—Hydroxyurea—brain cancer	0.000213	0.00174	CcSEcCtD
Gliclazide—Ill-defined disorder—Temozolomide—brain cancer	0.000213	0.00174	CcSEcCtD
Gliclazide—Leukopenia—Carmustine—brain cancer	0.000213	0.00174	CcSEcCtD
Gliclazide—Anaemia—Temozolomide—brain cancer	0.000212	0.00173	CcSEcCtD
Gliclazide—Diarrhoea—Procarbazine—brain cancer	0.000212	0.00173	CcSEcCtD
Gliclazide—Dyspepsia—Hydroxyurea—brain cancer	0.000211	0.00173	CcSEcCtD
Gliclazide—Agitation—Temozolomide—brain cancer	0.000211	0.00173	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000211	0.00373	CbGpPWpGaD
Gliclazide—Hypoaesthesia—Etoposide—brain cancer	0.00021	0.00172	CcSEcCtD
Gliclazide—Angioedema—Temozolomide—brain cancer	0.00021	0.00172	CcSEcCtD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000209	0.0037	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000207	0.00368	CbGpPWpGaD
Gliclazide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000207	0.00169	CcSEcCtD
Gliclazide—Malaise—Temozolomide—brain cancer	0.000207	0.00169	CcSEcCtD
Gliclazide—Fatigue—Hydroxyurea—brain cancer	0.000207	0.00169	CcSEcCtD
Gliclazide—Convulsion—Carmustine—brain cancer	0.000206	0.00168	CcSEcCtD
Gliclazide—Leukopenia—Temozolomide—brain cancer	0.000205	0.00168	CcSEcCtD
Gliclazide—Hypertension—Carmustine—brain cancer	0.000205	0.00168	CcSEcCtD
Gliclazide—Pain—Hydroxyurea—brain cancer	0.000205	0.00168	CcSEcCtD
Gliclazide—Constipation—Hydroxyurea—brain cancer	0.000205	0.00168	CcSEcCtD
Gliclazide—Dizziness—Procarbazine—brain cancer	0.000205	0.00168	CcSEcCtD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000205	0.00363	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000203	0.0036	CbGpPWpGaD
Gliclazide—Palpitations—Temozolomide—brain cancer	0.000203	0.00166	CcSEcCtD
Gliclazide—Myalgia—Carmustine—brain cancer	0.000202	0.00165	CcSEcCtD
Gliclazide—Chest pain—Carmustine—brain cancer	0.000202	0.00165	CcSEcCtD
Gliclazide—Anxiety—Carmustine—brain cancer	0.000201	0.00165	CcSEcCtD
Gliclazide—Cough—Temozolomide—brain cancer	0.0002	0.00164	CcSEcCtD
Gliclazide—Erythema multiforme—Etoposide—brain cancer	0.000199	0.00163	CcSEcCtD
Gliclazide—Convulsion—Temozolomide—brain cancer	0.000199	0.00163	CcSEcCtD
Gliclazide—Hypertension—Temozolomide—brain cancer	0.000198	0.00162	CcSEcCtD
Gliclazide—Feeling abnormal—Hydroxyurea—brain cancer	0.000198	0.00162	CcSEcCtD
Gliclazide—Eye disorder—Etoposide—brain cancer	0.000197	0.00161	CcSEcCtD
Gliclazide—Vomiting—Procarbazine—brain cancer	0.000197	0.00161	CcSEcCtD
Gliclazide—Flushing—Etoposide—brain cancer	0.000196	0.0016	CcSEcCtD
Gliclazide—Confusional state—Carmustine—brain cancer	0.000195	0.0016	CcSEcCtD
Gliclazide—Arthralgia—Temozolomide—brain cancer	0.000195	0.0016	CcSEcCtD
Gliclazide—Myalgia—Temozolomide—brain cancer	0.000195	0.0016	CcSEcCtD
Gliclazide—Rash—Procarbazine—brain cancer	0.000195	0.0016	CcSEcCtD
Gliclazide—Dermatitis—Procarbazine—brain cancer	0.000195	0.0016	CcSEcCtD
Gliclazide—Anxiety—Temozolomide—brain cancer	0.000195	0.00159	CcSEcCtD
Gliclazide—Headache—Procarbazine—brain cancer	0.000194	0.00159	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000194	0.00159	CcSEcCtD
Gliclazide—Discomfort—Temozolomide—brain cancer	0.000193	0.00158	CcSEcCtD
Gliclazide—Infection—Carmustine—brain cancer	0.000193	0.00157	CcSEcCtD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—HES1—brain cancer	0.000192	0.00341	CbGpPWpGaD
Gliclazide—KCNJ11—brain—brain cancer	0.000192	0.0282	CbGeAlD
Gliclazide—Dry mouth—Temozolomide—brain cancer	0.000191	0.00156	CcSEcCtD
Gliclazide—VEGFA—Focal Adhesion—VAV1—brain cancer	0.000191	0.00339	CbGpPWpGaD
Gliclazide—Thrombocytopenia—Carmustine—brain cancer	0.00019	0.00155	CcSEcCtD
Gliclazide—Body temperature increased—Hydroxyurea—brain cancer	0.00019	0.00155	CcSEcCtD
Gliclazide—Chills—Etoposide—brain cancer	0.000189	0.00155	CcSEcCtD
Gliclazide—Tachycardia—Carmustine—brain cancer	0.000189	0.00155	CcSEcCtD
Gliclazide—Confusional state—Temozolomide—brain cancer	0.000189	0.00154	CcSEcCtD
Gliclazide—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—brain cancer	0.000187	0.00332	CbGpPWpGaD
Gliclazide—Infection—Temozolomide—brain cancer	0.000186	0.00152	CcSEcCtD
Gliclazide—Nausea—Procarbazine—brain cancer	0.000184	0.00151	CcSEcCtD
Gliclazide—Nervous system disorder—Temozolomide—brain cancer	0.000184	0.0015	CcSEcCtD
Gliclazide—Thrombocytopenia—Temozolomide—brain cancer	0.000183	0.0015	CcSEcCtD
Gliclazide—Skin disorder—Temozolomide—brain cancer	0.000182	0.00149	CcSEcCtD
Gliclazide—Hypotension—Carmustine—brain cancer	0.000181	0.00148	CcSEcCtD
Gliclazide—Hyperhidrosis—Temozolomide—brain cancer	0.000181	0.00148	CcSEcCtD
Gliclazide—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.00018	0.00319	CbGpPWpGaD
Gliclazide—Back pain—Etoposide—brain cancer	0.000178	0.00145	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—BSG—brain cancer	0.000178	0.00315	CbGpPWpGaD
Gliclazide—Hypersensitivity—Hydroxyurea—brain cancer	0.000177	0.00144	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Carmustine—brain cancer	0.000177	0.00144	CcSEcCtD
Gliclazide—ABCC8—brain—brain cancer	0.000176	0.026	CbGeAlD
Gliclazide—Insomnia—Carmustine—brain cancer	0.000175	0.00143	CcSEcCtD
Gliclazide—Paraesthesia—Carmustine—brain cancer	0.000174	0.00142	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000173	0.00307	CbGpPWpGaD
Gliclazide—Dyspnoea—Carmustine—brain cancer	0.000173	0.00141	CcSEcCtD
Gliclazide—Somnolence—Carmustine—brain cancer	0.000172	0.00141	CcSEcCtD
Gliclazide—VEGFA—Allograft Rejection—IL2—brain cancer	0.000172	0.00305	CbGpPWpGaD
Gliclazide—Asthenia—Hydroxyurea—brain cancer	0.000172	0.00141	CcSEcCtD
Gliclazide—VEGFA—Cellular responses to stress—CDK6—brain cancer	0.000172	0.00304	CbGpPWpGaD
Gliclazide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000171	0.0014	CcSEcCtD
Gliclazide—Ill-defined disorder—Etoposide—brain cancer	0.00017	0.00139	CcSEcCtD
Gliclazide—Anaemia—Etoposide—brain cancer	0.00017	0.00139	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00017	0.00301	CbGpPWpGaD
Gliclazide—Insomnia—Temozolomide—brain cancer	0.000169	0.00139	CcSEcCtD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—STAT3—brain cancer	0.000169	0.003	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000169	0.003	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—EGFR—brain cancer	0.000169	0.00299	CbGpPWpGaD
Gliclazide—Paraesthesia—Temozolomide—brain cancer	0.000168	0.00138	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000167	0.00297	CbGpPWpGaD
Gliclazide—Gastrointestinal disorder—Carmustine—brain cancer	0.000167	0.00137	CcSEcCtD
Gliclazide—Dyspnoea—Temozolomide—brain cancer	0.000167	0.00137	CcSEcCtD
Gliclazide—Somnolence—Temozolomide—brain cancer	0.000167	0.00136	CcSEcCtD
Gliclazide—VEGFA—Axon guidance—TRPC6—brain cancer	0.000166	0.00295	CbGpPWpGaD
Gliclazide—Constipation—Carmustine—brain cancer	0.000166	0.00136	CcSEcCtD
Gliclazide—Pain—Carmustine—brain cancer	0.000166	0.00136	CcSEcCtD
Gliclazide—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.000166	0.00294	CbGpPWpGaD
Gliclazide—Malaise—Etoposide—brain cancer	0.000166	0.00135	CcSEcCtD
Gliclazide—Dyspepsia—Temozolomide—brain cancer	0.000165	0.00135	CcSEcCtD
Gliclazide—Leukopenia—Etoposide—brain cancer	0.000164	0.00134	CcSEcCtD
Gliclazide—Diarrhoea—Hydroxyurea—brain cancer	0.000164	0.00134	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Temozolomide—brain cancer	0.000162	0.00132	CcSEcCtD
Gliclazide—Fatigue—Temozolomide—brain cancer	0.000161	0.00132	CcSEcCtD
Gliclazide—Loss of consciousness—Etoposide—brain cancer	0.000161	0.00132	CcSEcCtD
Gliclazide—Cough—Etoposide—brain cancer	0.00016	0.00131	CcSEcCtD
Gliclazide—Constipation—Temozolomide—brain cancer	0.00016	0.00131	CcSEcCtD
Gliclazide—Pain—Temozolomide—brain cancer	0.00016	0.00131	CcSEcCtD
Gliclazide—Feeling abnormal—Carmustine—brain cancer	0.00016	0.00131	CcSEcCtD
Gliclazide—Convulsion—Etoposide—brain cancer	0.000159	0.0013	CcSEcCtD
Gliclazide—Hypertension—Etoposide—brain cancer	0.000159	0.0013	CcSEcCtD
Gliclazide—Dizziness—Hydroxyurea—brain cancer	0.000159	0.0013	CcSEcCtD
Gliclazide—Gastrointestinal pain—Carmustine—brain cancer	0.000158	0.0013	CcSEcCtD
Gliclazide—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000157	0.00278	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—PDGFRA—brain cancer	0.000156	0.00277	CbGpPWpGaD
Gliclazide—Chest pain—Etoposide—brain cancer	0.000156	0.00128	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000156	0.00276	CbGpPWpGaD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000155	0.00127	CcSEcCtD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000155	0.00274	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000155	0.00274	CbGpPWpGaD
Gliclazide—Discomfort—Etoposide—brain cancer	0.000154	0.00126	CcSEcCtD
Gliclazide—Feeling abnormal—Temozolomide—brain cancer	0.000154	0.00126	CcSEcCtD
Gliclazide—Abdominal pain—Carmustine—brain cancer	0.000153	0.00125	CcSEcCtD
Gliclazide—Body temperature increased—Carmustine—brain cancer	0.000153	0.00125	CcSEcCtD
Gliclazide—Gastrointestinal pain—Temozolomide—brain cancer	0.000153	0.00125	CcSEcCtD
Gliclazide—Vomiting—Hydroxyurea—brain cancer	0.000152	0.00125	CcSEcCtD
Gliclazide—VEGFA—Focal Adhesion—SPP1—brain cancer	0.000152	0.00269	CbGpPWpGaD
Gliclazide—Rash—Hydroxyurea—brain cancer	0.000151	0.00124	CcSEcCtD
Gliclazide—Confusional state—Etoposide—brain cancer	0.000151	0.00124	CcSEcCtD
Gliclazide—Dermatitis—Hydroxyurea—brain cancer	0.000151	0.00124	CcSEcCtD
Gliclazide—Headache—Hydroxyurea—brain cancer	0.00015	0.00123	CcSEcCtD
Gliclazide—Infection—Etoposide—brain cancer	0.000149	0.00122	CcSEcCtD
Gliclazide—Urticaria—Temozolomide—brain cancer	0.000149	0.00122	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000148	0.00263	CbGpPWpGaD
Gliclazide—Abdominal pain—Temozolomide—brain cancer	0.000148	0.00121	CcSEcCtD
Gliclazide—Body temperature increased—Temozolomide—brain cancer	0.000148	0.00121	CcSEcCtD
Gliclazide—Thrombocytopenia—Etoposide—brain cancer	0.000147	0.0012	CcSEcCtD
Gliclazide—Tachycardia—Etoposide—brain cancer	0.000146	0.0012	CcSEcCtD
Gliclazide—Skin disorder—Etoposide—brain cancer	0.000146	0.00119	CcSEcCtD
Gliclazide—Hyperhidrosis—Etoposide—brain cancer	0.000145	0.00119	CcSEcCtD
Gliclazide—Hypersensitivity—Carmustine—brain cancer	0.000143	0.00117	CcSEcCtD
Gliclazide—Nausea—Hydroxyurea—brain cancer	0.000142	0.00116	CcSEcCtD
Gliclazide—CYP2C19—endocrine gland—brain cancer	0.000142	0.0209	CbGeAlD
Gliclazide—Hypotension—Etoposide—brain cancer	0.00014	0.00115	CcSEcCtD
Gliclazide—Asthenia—Carmustine—brain cancer	0.000139	0.00114	CcSEcCtD
Gliclazide—Hypersensitivity—Temozolomide—brain cancer	0.000138	0.00113	CcSEcCtD
Gliclazide—ALB—Folate Metabolism—SOD2—brain cancer	0.000135	0.00239	CbGpPWpGaD
Gliclazide—Paraesthesia—Etoposide—brain cancer	0.000135	0.0011	CcSEcCtD
Gliclazide—Asthenia—Temozolomide—brain cancer	0.000134	0.0011	CcSEcCtD
Gliclazide—Dyspnoea—Etoposide—brain cancer	0.000134	0.00109	CcSEcCtD
Gliclazide—Somnolence—Etoposide—brain cancer	0.000133	0.00109	CcSEcCtD
Gliclazide—Diarrhoea—Carmustine—brain cancer	0.000133	0.00108	CcSEcCtD
Gliclazide—Pruritus—Temozolomide—brain cancer	0.000133	0.00108	CcSEcCtD
Gliclazide—VEGFA—Cellular responses to stress—SIRT1—brain cancer	0.000131	0.00232	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—CTNNB1—brain cancer	0.00013	0.00231	CbGpPWpGaD
Gliclazide—Gastrointestinal disorder—Etoposide—brain cancer	0.000129	0.00106	CcSEcCtD
Gliclazide—VEGFA—Cellular responses to stress—CCNE1—brain cancer	0.000129	0.00229	CbGpPWpGaD
Gliclazide—Fatigue—Etoposide—brain cancer	0.000129	0.00106	CcSEcCtD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—TP53—brain cancer	0.000129	0.00229	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000128	0.00227	CbGpPWpGaD
Gliclazide—Dizziness—Carmustine—brain cancer	0.000128	0.00105	CcSEcCtD
Gliclazide—Constipation—Etoposide—brain cancer	0.000128	0.00105	CcSEcCtD
Gliclazide—Pain—Etoposide—brain cancer	0.000128	0.00105	CcSEcCtD
Gliclazide—Diarrhoea—Temozolomide—brain cancer	0.000128	0.00105	CcSEcCtD
Gliclazide—ALB—brain—brain cancer	0.000126	0.0186	CbGeAlD
Gliclazide—VEGFA—Cellular responses to stress—SOD2—brain cancer	0.000126	0.00223	CbGpPWpGaD
Gliclazide—Dizziness—Temozolomide—brain cancer	0.000124	0.00101	CcSEcCtD
Gliclazide—Feeling abnormal—Etoposide—brain cancer	0.000124	0.00101	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—OR4C12—brain cancer	0.000123	0.00219	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—OR14C36—brain cancer	0.000123	0.00219	CbGpPWpGaD
Gliclazide—Vomiting—Carmustine—brain cancer	0.000123	0.00101	CcSEcCtD
Gliclazide—VEGFA—Signaling by VEGF—CTNNB1—brain cancer	0.000123	0.00218	CbGpPWpGaD
Gliclazide—Gastrointestinal pain—Etoposide—brain cancer	0.000123	0.001	CcSEcCtD
Gliclazide—Rash—Carmustine—brain cancer	0.000122	0.001	CcSEcCtD
Gliclazide—Dermatitis—Carmustine—brain cancer	0.000122	0.000999	CcSEcCtD
Gliclazide—Headache—Carmustine—brain cancer	0.000121	0.000993	CcSEcCtD
Gliclazide—VEGFA—Focal Adhesion—PIK3CG—brain cancer	0.000121	0.00215	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000121	0.00214	CbGpPWpGaD
Gliclazide—Vomiting—Temozolomide—brain cancer	0.000119	0.000974	CcSEcCtD
Gliclazide—Urticaria—Etoposide—brain cancer	0.000119	0.000974	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—TRPC6—brain cancer	0.000119	0.0021	CbGpPWpGaD
Gliclazide—Abdominal pain—Etoposide—brain cancer	0.000118	0.000969	CcSEcCtD
Gliclazide—Body temperature increased—Etoposide—brain cancer	0.000118	0.000969	CcSEcCtD
Gliclazide—Rash—Temozolomide—brain cancer	0.000118	0.000966	CcSEcCtD
Gliclazide—Dermatitis—Temozolomide—brain cancer	0.000118	0.000965	CcSEcCtD
Gliclazide—Headache—Temozolomide—brain cancer	0.000117	0.00096	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—TRPC6—brain cancer	0.000116	0.00206	CbGpPWpGaD
Gliclazide—Nausea—Carmustine—brain cancer	0.000115	0.000942	CcSEcCtD
Gliclazide—Nausea—Temozolomide—brain cancer	0.000111	0.00091	CcSEcCtD
Gliclazide—Hypersensitivity—Etoposide—brain cancer	0.00011	0.000903	CcSEcCtD
Gliclazide—ABCC8—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00011	0.00196	CbGpPWpGaD
Gliclazide—CYP2C9—endocrine gland—brain cancer	0.00011	0.0162	CbGeAlD
Gliclazide—Asthenia—Etoposide—brain cancer	0.000108	0.00088	CcSEcCtD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.000107	0.0019	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—SOD2—brain cancer	0.000107	0.0019	CbGpPWpGaD
Gliclazide—Pruritus—Etoposide—brain cancer	0.000106	0.000867	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—DTX2—brain cancer	0.000105	0.00186	CbGpPWpGaD
Gliclazide—Diarrhoea—Etoposide—brain cancer	0.000103	0.000839	CcSEcCtD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—CCND1—brain cancer	9.99e-05	0.00177	CbGpPWpGaD
Gliclazide—Dizziness—Etoposide—brain cancer	9.91e-05	0.000811	CcSEcCtD
Gliclazide—VEGFA—Cellular responses to stress—CDK4—brain cancer	9.9e-05	0.00176	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	9.9e-05	0.00175	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—CTNNB1—brain cancer	9.64e-05	0.00171	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—RELA—brain cancer	9.57e-05	0.0017	CbGpPWpGaD
Gliclazide—Vomiting—Etoposide—brain cancer	9.53e-05	0.000779	CcSEcCtD
Gliclazide—Rash—Etoposide—brain cancer	9.45e-05	0.000773	CcSEcCtD
Gliclazide—Dermatitis—Etoposide—brain cancer	9.44e-05	0.000772	CcSEcCtD
Gliclazide—VEGFA—Focal Adhesion—ERBB2—brain cancer	9.41e-05	0.00167	CbGpPWpGaD
Gliclazide—Headache—Etoposide—brain cancer	9.39e-05	0.000768	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	9.37e-05	0.00166	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—MPL—brain cancer	9.28e-05	0.00165	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYP2C9—brain cancer	9.27e-05	0.00164	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYP2C9—brain cancer	8.99e-05	0.00159	CbGpPWpGaD
Gliclazide—Nausea—Etoposide—brain cancer	8.9e-05	0.000728	CcSEcCtD
Gliclazide—ALB—Hemostasis—S100A10—brain cancer	8.89e-05	0.00158	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—VAV1—brain cancer	8.72e-05	0.00155	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—CCND1—brain cancer	8.32e-05	0.00147	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	8.28e-05	0.00147	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—CTNNB1—brain cancer	8.24e-05	0.00146	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	8.2e-05	0.00145	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—MYC—brain cancer	8.02e-05	0.00142	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	7.97e-05	0.00141	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PTCH2—brain cancer	7.94e-05	0.00141	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—BSG—brain cancer	7.88e-05	0.0014	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—EGFR—brain cancer	7.84e-05	0.00139	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—RELA—brain cancer	7.79e-05	0.00138	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	7.7e-05	0.00137	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HES5—brain cancer	7.69e-05	0.00136	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—HES1—brain cancer	7.65e-05	0.00136	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—BSG—brain cancer	7.64e-05	0.00135	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CDKN2A—brain cancer	7.57e-05	0.00134	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—IL2—brain cancer	7.56e-05	0.00134	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—STRADA—brain cancer	7.47e-05	0.00132	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—RELA—brain cancer	7.28e-05	0.00129	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL2—brain cancer	7.02e-05	0.00124	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—IDH1—brain cancer	6.78e-05	0.0012	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.71e-05	0.00119	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.64e-05	0.00118	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—TP53—brain cancer	6.58e-05	0.00117	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—IDH1—brain cancer	6.57e-05	0.00117	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—EGFR—brain cancer	6.52e-05	0.00116	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	6.5e-05	0.00115	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—BSG—brain cancer	6.27e-05	0.00111	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ABR—brain cancer	6.23e-05	0.00111	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—RELA—brain cancer	6.19e-05	0.0011	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—ERBB2—brain cancer	6.14e-05	0.00109	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.02e-05	0.00107	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GLI2—brain cancer	6.02e-05	0.00107	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—CDK4—brain cancer	6e-05	0.00106	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	5.97e-05	0.00106	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GLI1—brain cancer	5.66e-05	0.001	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—PIK3CG—brain cancer	5.54e-05	0.000982	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—STAT3—brain cancer	5.52e-05	0.000978	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5.46e-05	0.000967	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SUFU—brain cancer	5.37e-05	0.000951	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ENO2—brain cancer	5.36e-05	0.00095	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ENO2—brain cancer	5.19e-05	0.000921	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GFAP—brain cancer	5.18e-05	0.000918	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—VEGFA—brain cancer	5.11e-05	0.000906	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HEY1—brain cancer	4.91e-05	0.00087	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.91e-05	0.00087	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	4.87e-05	0.000863	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DLL1—brain cancer	4.81e-05	0.000853	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TP53—brain cancer	4.5e-05	0.000799	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—RELA—brain cancer	4.41e-05	0.000782	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.4e-05	0.000781	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—ERBB2—brain cancer	4.38e-05	0.000777	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—EGFR—brain cancer	4.26e-05	0.000755	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—TP53—brain cancer	4.21e-05	0.000747	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TRPC6—brain cancer	4.11e-05	0.000728	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SHH—brain cancer	4.09e-05	0.000726	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.02e-05	0.000712	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TRPC6—brain cancer	3.95e-05	0.0007	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IL2—brain cancer	3.9e-05	0.000691	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SMO—brain cancer	3.88e-05	0.000688	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PTCH1—brain cancer	3.88e-05	0.000688	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—CTNNB1—brain cancer	3.83e-05	0.00068	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	3.79e-05	0.000672	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	3.56e-05	0.00063	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—STAT3—brain cancer	3.34e-05	0.000593	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOTCH2—brain cancer	3.1e-05	0.00055	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—VAV1—brain cancer	3.08e-05	0.000546	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—EGFR—brain cancer	3.04e-05	0.000539	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP2C9—brain cancer	2.99e-05	0.00053	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—VAV1—brain cancer	2.96e-05	0.000524	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP2C9—brain cancer	2.68e-05	0.000476	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	2.67e-05	0.000473	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HES1—brain cancer	2.54e-05	0.000451	CbGpPWpGaD
Gliclazide—ALB—Metabolism—BSG—brain cancer	2.54e-05	0.000451	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TP53—brain cancer	2.5e-05	0.000444	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PIK3CG—brain cancer	2.46e-05	0.000436	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PDGFRA—brain cancer	2.42e-05	0.000429	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PIK3CG—brain cancer	2.38e-05	0.000423	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SPP1—brain cancer	2.35e-05	0.000417	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—BSG—brain cancer	2.28e-05	0.000404	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	2.27e-05	0.000402	CbGpPWpGaD
Gliclazide—ALB—Metabolism—IDH1—brain cancer	2.18e-05	0.000387	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IRS2—brain cancer	2.13e-05	0.000377	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—BSG—brain cancer	2.08e-05	0.000369	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—IDH1—brain cancer	1.96e-05	0.000348	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PIK3CG—brain cancer	1.95e-05	0.000347	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—APC—brain cancer	1.88e-05	0.000333	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PIK3CG—brain cancer	1.88e-05	0.000333	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—IDH1—brain cancer	1.79e-05	0.000317	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.78e-05	0.000315	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ENO2—brain cancer	1.73e-05	0.000306	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.6e-05	0.000283	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ENO2—brain cancer	1.55e-05	0.000275	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RELA—brain cancer	1.47e-05	0.00026	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ERBB2—brain cancer	1.46e-05	0.000258	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.46e-05	0.000258	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ENO2—brain cancer	1.41e-05	0.000251	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IL2—brain cancer	1.38e-05	0.000244	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL2—brain cancer	1.32e-05	0.000234	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCND1—brain cancer	1.29e-05	0.000228	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CTNNB1—brain cancer	1.28e-05	0.000226	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—VEGFA—brain cancer	1.17e-05	0.000207	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—STAT3—brain cancer	1.11e-05	0.000197	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MYC—brain cancer	1.03e-05	0.000183	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EGFR—brain cancer	1.01e-05	0.000179	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TP53—brain cancer	8.83e-06	0.000157	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TP53—brain cancer	8.48e-06	0.00015	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PIK3CG—brain cancer	7.92e-06	0.00014	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PIK3CG—brain cancer	7.11e-06	0.000126	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PIK3CG—brain cancer	6.49e-06	0.000115	CbGpPWpGaD
